V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280003311 | 280002485 | 1.61 | 84.1 | Curative (C) | 2014-05-18 | 2014-05-18 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025357 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003312 | 280002485 | 1.65 | 93 | Neo-adjuvant (N) | 2014-05-16 | 2014-05-27 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 280025357 | CISPLATIN + FLUOROURACIL |
| 280003313 | 280002486 | 1.78 | 57.2 | Not known (9) | 2013-12-06 | 2013-12-26 | CETUXIMAB + RT | 02 | Y | 280025362 | CETUXIMAB + RT |
| 280003314 | 280002486 | 1.8 | 88.7 | null | 2017-03-27 | 2017-04-03 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025362 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003315 | 280002486 | 1.6 | null | Neo-adjuvant (N) | 2017-12-08 | 2017-12-13 | Doxorubicin + Ifosfamide | 02 | N | 280025362 | DOXORUBICIN + IFOSFAMIDE |
| 280003316 | 280002486 | null | 84.1 | Curative (C) | 2016-07-28 | 2016-08-15 | CETUXIMAB + RT | 02 | N | 280025362 | CETUXIMAB + RT |
| 280003317 | 280002487 | 1.5 | 64.2 | Neo-adjuvant (N) | 2015-08-15 | 2015-08-22 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025367 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003318 | 280002488 | 1.73 | 53.3 | Neo-adjuvant (N) | 2017-12-26 | 2018-01-10 | Cisplatin +Fluorouracil (3 wk) | null | N | 280025368 | CISPLATIN + FLUOROURACIL |
| 280003319 | 280002489 | 1.68 | 77.4 | Curative (C) | 2013-09-07 | 2013-09-08 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025369 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003320 | 280002490 | 0 | 64.5 | Neo-adjuvant (N) | 2013-02-10 | 2013-02-18 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025370 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003321 | 280002491 | 1.65 | 89 | Palliative (P) | 2017-12-13 | 2016-11-05 | Doxorubicin + Ifosfamide | N | N | 280025371 | DOXORUBICIN + IFOSFAMIDE |
| 280003322 | 280002492 | 1.83 | 86.4 | Palliative (P) | 2017-06-03 | 2017-07-13 | DOXORUBICIN + IFOSFAMIDE | N | N | 280025373 | DOXORUBICIN + IFOSFAMIDE |
| 280003323 | 280007280 | 1.47 | 91.9 | Neo-adjuvant (N) | 2014-09-05 | 2014-09-14 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025374 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003324 | 280007280 | 1.65 | 71.8 | Palliative (P) | null | 2015-07-24 | DOXORUBICIN + IFOSFAMIDE | null | null | 280025374 | DOXORUBICIN + IFOSFAMIDE |
| 280003325 | 280002493 | 1.77 | null | Curative (C) | 2015-03-28 | 2015-04-22 | Doxorubicin + Ifosfamide | N | N | 280025381 | DOXORUBICIN + IFOSFAMIDE |
| 280003326 | 280002494 | null | 83.1 | Neo-adjuvant (N) | 2017-01-06 | 2017-01-24 | CISPLATIN + FLUOROURACIL | N | N | 280025382 | CISPLATIN + FLUOROURACIL |
| 280003327 | 280002495 | null | 77.2 | Neo-adjuvant (N) | 2017-09-30 | 2017-09-30 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025383 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003328 | 280002496 | 1.58 | 68.3 | Curative (C) | 2017-04-16 | 2017-05-15 | Cetuximab + Radiotherapy Load | N | Y | 280025384 | CETUXIMAB + RT |
| 280003329 | 280002497 | 1.74 | null | Neo-adjuvant (N) | 2015-10-25 | 2015-11-13 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025386 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003330 | 280002498 | 1.75 | null | Neo-adjuvant (N) | 2015-01-28 | 2015-02-14 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025388 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003331 | 280002498 | 1.68 | 81.5 | Curative (C) | 2015-05-09 | 2015-06-04 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025388 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003332 | 280002499 | 1.73 | 80.5 | Neo-adjuvant (N) | 2013-03-12 | 2013-04-07 | CISPLATIN + FLUOROURACIL | 02 | N | 280025394 | CISPLATIN + FLUOROURACIL |
| 280003333 | 280007282 | 1.8 | 76.1 | Neo-adjuvant (N) | 2014-01-11 | 2014-01-22 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025395 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003334 | 280002500 | 1.72 | 53.7 | null | 2015-10-25 | 2015-12-07 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025397 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003335 | 280002501 | 1.55 | 85.9 | null | 2015-10-01 | 2015-10-14 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025399 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003336 | 280002502 | null | 81 | Neo-adjuvant (N) | 2013-09-05 | 2013-09-06 | Cisplatin +Fluorouracil (3 wk) | N | N | 280025401 | CISPLATIN + FLUOROURACIL |
| 280003337 | 280002503 | 1.8 | 75.1 | Neo-adjuvant (N) | 2013-03-24 | 2013-03-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 280025403 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003338 | 280007283 | 1.63 | null | Neo-adjuvant (N) | 2017-11-19 | 2017-11-19 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025407 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003339 | 280007283 | 1.85 | 90.6 | Not known (9) | 2015-08-17 | 2015-08-18 | CETUXIMAB + RT | N | Y | 280025407 | CETUXIMAB + RT |
| 280003340 | 280002504 | 1.8 | 89.1 | Curative (C) | 2015-06-08 | 2015-06-17 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 280025409 | CISPLATIN + FLUOROURACIL |
| 280003341 | 280002505 | 1.67 | 98 | Curative (C) | 2016-09-28 | 2016-10-11 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025411 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003342 | 280002505 | 1.7 | 81 | Not known (9) | null | 2016-02-13 | Cisplatin +Fluorouracil (3 wk) | N | N | 280025411 | CISPLATIN + FLUOROURACIL |
| 280003343 | 280002505 | 1.62 | 93.3 | Curative (C) | 2016-12-13 | 2016-12-13 | Cetuximab + Radiotherapy Load | N | Y | 280025411 | CETUXIMAB + RT |
| 280003344 | 280002506 | 1.55 | 77.5 | null | 2017-02-04 | 2017-02-17 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025416 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003345 | 280002507 | 1.7 | 92.4 | Neo-adjuvant (N) | 2017-07-27 | 2017-08-01 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 280025419 | CISPLATIN + FLUOROURACIL |
| 280003346 | 280002508 | null | 76.7 | null | 2016-06-09 | 2016-06-09 | Cetuximab + Radiotherapy Load | 02 | N | 280025420 | CETUXIMAB + RT |
| 280003347 | 280002509 | 1.51 | 103.7 | Neo-adjuvant (N) | 2015-02-04 | 2015-03-09 | Cisplatin + Docetaxel +Fluorouracil | N | Y | 280025421 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003348 | 280002510 | 1.72 | 92.2 | Curative (C) | 2017-10-11 | 2017-11-21 | CETUXIMAB + RT | N | Y | 280025422 | CETUXIMAB + RT |
| 280003349 | 280002511 | 1.76 | 85.1 | Curative (C) | 2017-06-18 | 2017-06-18 | CETUXIMAB + RT | null | null | 280025423 | CETUXIMAB + RT |
| 280003350 | 280002511 | 1.76 | 64.6 | Neo-adjuvant (N) | 2014-12-10 | 2016-12-05 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025423 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003351 | 280002511 | 1.5 | 63 | Neo-adjuvant (N) | 2015-01-04 | 2015-01-04 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025423 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003352 | 280010924 | 1.75 | 88.9 | Not known (9) | 2013-07-13 | 2013-08-21 | CISPLATIN + FLUOROURACIL | N | N | 280025426 | CISPLATIN + FLUOROURACIL |
| 280003353 | 280002512 | null | null | Curative (C) | 2014-05-02 | 2014-05-08 | Cetuximab + Radiotherapy Maint | 02 | Y | 280025427 | CETUXIMAB + RT |
| 280003354 | 280002513 | 1.83 | 98 | Curative (C) | 2015-07-20 | 2015-08-24 | CETUXIMAB + RT | N | Y | 280025431 | CETUXIMAB + RT |
| 280003355 | 280002513 | 1.59 | 55.6 | null | 2013-11-21 | 2013-11-21 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | null | 280025431 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003356 | 280002513 | 1.62 | 64 | Curative (C) | null | 2015-02-23 | CISPLATIN + FLUOROURACIL | null | null | 280025431 | CISPLATIN + FLUOROURACIL |
| 280003357 | 280002514 | 1.58 | 75.1 | Palliative (P) | 2016-02-25 | 2016-03-16 | DOXORUBICIN + IFOSFAMIDE | 02 | N | 280025437 | DOXORUBICIN + IFOSFAMIDE |
| 280003358 | 280002515 | 1.8 | 79.4 | Curative (C) | 2015-06-11 | 2015-06-17 | CETUXIMAB + RT | 2 | Y | 280025438 | CETUXIMAB + RT |
| 280003359 | 280002516 | 1.76 | 152.2 | Curative (C) | 2014-10-15 | 2014-10-22 | CETUXIMAB + RT | N | Y | 280025444 | CETUXIMAB + RT |
| 280003360 | 280007287 | 1.71 | 94.5 | Disease modification (D) | 2017-09-07 | 2017-09-20 | Doxorubicin + Ifosfamide | 02 | null | 280025445 | DOXORUBICIN + IFOSFAMIDE |